DHT binds to androgen receptors in hair follicles, triggering a miniaturization process that progressively shrinks follicles until they can no longer produce visible hair
[1] At the same time, GLP-1 prevents your body from secreting glucagon, a hormone that the body uses to raise blood sugar when needed
Remove the orange cap from the needle
Clinical guidelines generally recommend GLP-1-based therapies for adults with obesity, usually defined as a BMI above 30, or for overweight patients with additional health risks such as type 2 diabetes, high blood pressure, fatty liver disease, sleep apnoea or cardiovascular complications
"Reactivate Your GLP-1" - Brand-stated marketing language from glpatch.shop
JAMA 319 (14), 14291430 (2018)